Pharmacogenetic screening: HLA-B*5701 vs. CYP2B6 G516T

被引：3
|
作者：
Lin, A. W. C. [1 ]
Yam, W-C [2 ]
Lam, H-Y [2 ]
To, S. [2 ]
Chan, D. [3 ]
Chan, K. C. W. [1 ]
Lee, S-S [4 ]
机构：
[1] Ctr Hlth Protect, Dept Hlth, Special Prevent Programme, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Fac Med, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Dept Microbiol, Shatin, Hong Kong, Peoples R China
来源：
HIV MEDICINE | 2011年 / 12卷 / 04期
关键词：
SOUTHERN CHINESE; EFAVIRENZ;
D O I：
10.1111/j.1468-1293.2010.00870.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：255 / 256
页数：2
相关论文
共 50 条
  • [1] The implications of a high allelic frequency of CYP2B6 G516T in ethnic Chinese persons
    Tong, Kenneth
    He, Ming-Liang
    Lin, Che-Kit
    Guo, Liping
    Kung, Hsiang-Fu
    Sung, Joseph J. Y.
    Lee, Shui-Shan
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 (04) : 541 - 542
  • [2] ASSOCIATION OF CYP2B6 G516T POLYMORPHISM WITH THE SUSCEPTIBILITY OF de novo ACUTE MYELOGENOUS LEUKEMIA
    Daraki, A.
    Zachaki, S.
    Koromila, T.
    Karakosta, M.
    Pantelias, G.
    Aleporou, V.
    Sambani, C.
    Kollia, P.
    Manola, K.
    [J]. HAEMATOLOGICA, 2012, 97 : 262 - 262
  • [3] GENETIC VARIABILITY OF CYP2B6 G516T AND THEIR IMPACT IN EFAVIRENZ BASED HAART: A META-ANALYSIS
    Mulugeta, Anwar
    Eyakim, Abiy H.
    Belew, Yewbdar
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (03): : 763 - 772
  • [4] THE G516T POLYMORPHISM OF CYP2B6 GENE AS A POSSIBLE PREDISPOSING FACTOR FOR THE DEVELOPMENT OF ACUTE MYELOID LEUKEMIA
    Daraki, A.
    Zachaki, S.
    Koromila, T.
    Pantelias, G.
    Aleporou, V.
    Sambani, C.
    Kollia, P.
    Manola, K. N.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 : S2 - S2
  • [5] The Clinical Spectrum and G516T CYP2B6 Single Nucleotide Polymorphism in Efavirenz Drug Induced Liver Injury
    Sonderup, Mark W.
    Abdullah, Gadija
    Davidson, Brandon
    Maughan, Deborah
    Gogela, Neliswa
    Spearman, Catherine Wendy
    [J]. HEPATOLOGY, 2018, 68 : 210A - 210A
  • [6] Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
    Penzak, S. R.
    Kabuye, G.
    Mugyenyi, P.
    Mbamanya, F.
    Natarajan, V.
    Alfaro, R. M.
    Kityo, C.
    Formentini, E.
    Masur, H.
    [J]. HIV MEDICINE, 2007, 8 (02) : 86 - 91
  • [7] The G516T CYP2B6 Germline Polymorphism Affects the Risk of Acute Myeloid Leukemia and Is Associated with Specific Chromosomal Abnormalities
    Daraki, Aggeliki
    Zachaki, Sophia
    Koromila, Theodora
    Diamantopoulou, Paraskevi
    Pantelias, Gabriel E.
    Sambani, Constantina
    Aleporou, Vasiliki
    Kollia, Panagoula
    Manola, Kalliopi N.
    [J]. PLOS ONE, 2014, 9 (02):
  • [8] IMPLICATIONS OF SCREENING FOR CYP2B6 516G>T SNP ON HIV/AIDS PATIENTS
    Swart, M.
    Dandara, C.
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 163 - 164
  • [9] HLA-B*5701 screening for hypersensitivity to abacavir
    Faruki, Hawazin
    Lai-Goldman, Myla
    [J]. PERSONALIZED MEDICINE, 2008, 5 (03) : 297 - 300
  • [10] HLA-B*5701 screening for hypersensitivity to abacavir
    Mallal, Simon
    Phillips, Elizabeth
    Carosi, Giampiero
    Molina, Jean-Michel
    Workman, Cassy
    Tomazic, Janez
    Jaegel-Guedes, Eva
    Rugina, Sorin
    Kozyrev, Oleg
    Cid, Juan Flores
    Hay, Phillip
    Nolan, David
    Hughes, Sara
    Hughes, Arlene
    Ryan, Susanna
    Fitch, Nicholas
    Thorborn, Daren
    Benbow, Alastair
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (06): : 568 - 579
12345